维普中文期刊产品整合服务
20篇 您的检索式:作者名="Yoon CL"
    题名 作者 年代 出处 被引量
1Entecavir treatment for up to 5years in patients with hepatitis Be antigen-positive chronic hepatitis B显示文摘Chang TT Lai CL Kew Yoon S 2010Hepatology2010,51,2:1
2Risk {actors for venous thromboembolism among reproductive age women 显示文摘Westhoff CL Yoon LS Tang R 2016J Womens Heahh2016,25,1:1
3Entecavir treat- ment or up to 5 years in patients with hepatitis B e antigen- positive chronic hepatitis B显示文摘Chang TT Lai CL Kew Yoon SK 2010J Hepatol2010,51,2:1
4Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B显示文摘Chang TT Lai CL Kew Yoon S 2010Hepatology2010,51,2:1
5Entecavir treatment for up to 5 years in patients with hepatitis B e Antigen-Positive chronic hepatitis B显示文摘Chang TT Lai CL Yoon SK 2010Hepatology2010,51,2:1
6Entecavir treatment for up to5 years in patients with hepatitis B e antigen-positive chronic hepatitis B显示文摘Chang TT Lai CL Kew Yoon S 2010Hepatology2010,51,:1
7Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B 显示文摘Chang TT Lai CL Yoon SK 2010Hepatology2010,51,:1
8Entecavir treatment for up to 5 years in patients with hepatitis Be antigen- positive chronic hepatitis B显示文摘Chang TT Lai CL Yoon SK 2010H epatology2010,51,2:1
9Enhanced osteogenic promotion around dental implantswith synthetic binding motif mimicking bone morphogenetic protein (BMP) - 2 显示文摘Yang JS Yoon JP Sang CL 2006J Biomed Mater Res2006,77,3:1
10The diversity of dental patterns in the orthopantomography and its significance in human identification 显示文摘Lee SS Choi JH Yoon CL 2004J Forensic Sci2004,49,:1
11Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B 显示文摘Chang TY Lai CL Kew Yoon S 2010Hepatology2010,51,2:1
12Enteeavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B 显示文摘Chang TT Lai CL Kew Yoon S 2010Hepatology2010,51,2:1
13Characterization of inhibitors of specific carboxylesterases:development of carboxylesterase inhibitors for translational application显示文摘 Hyatt JL Morton CL 2004Mol Cancer Ther2004,3,8:1
14Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B显示文摘Chang TT Lai CL Kew Yoon S 0,,2:1
15Phase Ⅱ, multi-center, dose-escalating study of LB80380 (ANA380) in hepatitis B patients with lamivudine-resistant YMDD mutant HBV显示文摘Lai CL Han KH Yoon SK 2006J Hepatol2006,44,2:1
16Entecavir treatment for up to5 years in patients with hepatitis B e antigen-positive chronichepatitis B 显示文摘Chang TT Lai CL Kew Yoon S 2010Hepatology2010,51,2:1
17Entecavir treatment for up to 5 years in patients with hepatitis B e antigen- positive chronic hepatitis B显示文摘Chang TT Lai CL Kew Yoon S 2010Hepa- tology2010,51,2:1
18Characterization of inhibitors of specific carboxylesterases:development of carboxylesterase inhibition for translational application显示文摘Yoon K J Hyatt JL Morton CL 2004Mol Cancer Ther2004,3,8:1
19Entecavir treatment for up to 5 years in patients with hepatitis B e antigen -- positive chronic hepatitis B 显示文摘Chug TT Lai CL Kew Yoon S 2010Hepatology2010,51,2:1
20Characterization of inhibitors of specific carboxylesterases:development of carboxylesterase inhibitors for translational application显示文摘Yoon KJ Hyatt JL Morton CL 2004Mol Cancer Ther2004,3,8:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费